Henk Derksen
Analyst · Needham & Company
Thank you, Sagar. Fiscal Q4 2022 set an all-time record for Viavi revenue and a fourth quarter record for non-GAAP profitability. Fourth quarter revenue came in at $335.3 million, up 7.8% year-over-year, exceeding our guidance range of $315 million to $329 million. Growth was primarily driven by improved demand for our core OSP and 3D sensing products. Viavi's operating profit margin at 21.3% was within our guidance range of 21% to 22%, improving 50 basis points year-over-year. EPS at $0.24 met the high end of our $0.22 to $0.24 guidance range and increased 9.1% from $0.22 in the prior year, a combination of strong operating performance and the impact of an improving capital structure. The fully dilutive shares outstanding at the end of fiscal Q4 2022 of 231.3 million shares decreased from 241.9 million shares in the year ago period, substantially a result of refinancing our convertible debt while continuing to execute on our share repurchase program during fiscal 2022. The outstanding dilution resulting from the remaining convertible notes was 1.6 million shares during the fourth quarter, compared to 10.4 million shares a year ago. Moving on to our reported Q4 results by business segment, starting with NSE. NSE quarterly revenue at $246.2 million, up 4.1% year-over-year was within our guided range of $240 million to $250 million, a new quarterly record in this business segment. Within NSE, NE increased 4.5% from a year ago to $222.2 million reflecting continued strong demand for our wireless and optical lab and production products. SE revenue at $24 million was flat year-over-year albeit at an improved product mix. NSE gross profit margin at 64.9% increased 150 basis points year-over-year. Within NSE, NE gross profit margin at 64.2% increased 110 basis points from last year, primarily a result of leverage on growth and favorable product mix. SE gross profit margin at 71.3% increased 580 basis points year-over-year. NSE's operating profit margin at 15.1% was slightly below our guidance range, albeit flat year-over-year. Higher variable sales commission costs on strong bookings performance during the quarter was offset by gross profit margin expansion. Now turning to OSP. Fourth quarter revenue at $89.1 million was up 19.8% from a year ago and improved sequentially by 5.2%. Revenue exceeded the guidance range of $75 million to $79 million due to better-than-expected demand for anti-counterfeiting products during the quarter. Gross profit margin at 55.9% decreased 160 basis points year-over-year driven primarily by raw material costs and start-up costs in our new Arizona facility. Operating profit margin at 38.6% was within our guidance range of 38.5% to 39.5%, although down 20 basis points year-over-year, a result of the aforementioned gross margin factors offset by disciplined OpEx management. Moving to our fiscal 2022 full year performance. Despite the COVID-19 pandemic-related supply chain issues and inflationary pressures, Viavi was able to mitigate much of the impact, resulting in a strong finish to a record of $1.3 million, up 7.8% from fiscal 2021. NSE reached a record revenue of $949.1 million, up 13.3% year-over-year, well within the range of our long-term goal. OSP at $343.3 million saw a modest decline of 4.9% in revenue compared to record levels in 2021 but still exceeded the high end of our 2022 goal provided in 2019. Viavi's full year 2022 operating profit margin at 22.2%, expanded 110 basis points and exceeded the high end of our goal of 21% by 120 basis points. Within our NSE segment, operating profit margins expanded 460 basis points from 11% in 2021 to 15.6% in 2022 due to leverage on revenue growth, combined with disciplined OpEx management. Within our OSP segment, operating profit margins reduced from a record level of 44.7% in 2021 to 40.5% in 2022, a result of lower revenues in combination with higher raw material costs. Full year 2022 EPS at $0.95 increased 14.5% or $0.12 from $0.83 in 2021 and is ahead of the high end of our goal of $0.90 for 2022, a result of operating performance and an improved tax rate. Now turning to the balance sheet. At the end of fiscal Q4 2022, the ending balance of our total cash and short-term investments was $565 million, down $139 million compared to a year ago, mainly a result of refinancing 57% of our convertible debt with longer notes at a favorable rate. During 2022, we generated $178 million in operating cash flow and deployed $73 million or 5.6% of revenues towards capital expenditures, resulting into $106 million in free cash flow generation. We were able to buy back $45.5 million in common shares under the 2019 repurchase program and invested $8.3 million in M&A activity. Looking at just the fourth quarter, operating cash flow was strong at $73.6 million, an increase of $11 million compared to $62.6 million in the year ago period. The increase as a result of higher operating income, coupled with benefits from supply chain investments made earlier in the year. In addition, we invested $19.1 million in capital expenditures during the quarter, compared to $25.4 million in the prior year as we progress towards completion of our Arizona production facility. As you may recall, we had targeted the reduction of our 2023 and 2024 outstanding convertible notes to continue to improve our capital structure. During the first three quarters of 2022, we redeemed approximately $370.6 million of these notes on the original $685 million in principal value. In the fourth quarter, we completed transactions to extinguish an additional $22.4 million in principal value of convertible loans at a total reacquisition cost of $27.2 million, bringing the principal value of our combined convertible notes outstanding to $292 million at the end of fiscal 2022, or 43% of the original principal value. During fiscal Q4, we repurchased 2.1 million shares of common stock for $28.9 million, under the 2019 repurchase plan. The remaining authorization under the 2019 repurchase plan is $67.3 million. Now on to our guidance. We expect the fiscal first quarter 2023 revenue to be approximately $324 million, plus or minus $7 million. Operating profit margin is expected to be 21.4%, plus or minus 70 basis points and EPS to be in the range of $0.22 to $0.24. We expect NSE revenue to be approximately $236 million, plus or minus $5 million, with operating profit margin at 14.5% plus or minus 50 basis points. OSP revenue is expected to be approximately $88 million, plus or minus $2 million, with operating profit margin at 40%, plus or minus 100 basis points. Our tax rate is expected to be approximately 16% to 17% and we expect other income and expenses to reflect a net expense of approximately $6 million. Share count is approximately 232 million shares based on current stock price levels and includes the dilutive impact of approximately $2.5 million of the remaining convertible notes. With that, I will turn the call over to Oleg.